Toggle Health Problems and D

Off topic: Large dose of Vitamin A increased allergic reaction in girls by 1.8X – RCT May 2015

Neonatal vitamin A supplementation associated with increased atopy in girls

Allergy, DOI: 10.1111/all.12641
Sofie Aage1,2,*, Nicholas Kiraly3, Kassarai Da Costa1, Stine Byberg1,2,4, Morten Bjerregaard-Andersen1,2, Ane B. Fisker1,2, Peter Aaby1,2 andChristine S. Benn1,2,4

VitaminDWiki Summary

(50,000 IU retinyl palmitate) to new infants
A decade later the girls had increased risk of reaction to skin prick test
VitaminDWiki wonders if this is due to Vitamin A blocking Vitamin D receptors

Neonatal vitamin A supplementation (NVAS) is currently being considered as policy in countries at risk of deficiency. A previous study suggested that NVAS may be associated with increased atopy. We examined the effect of NVAS on atopy by conducting long-term follow-up of a previous randomised controlled trial in Guinea-Bissau.

In 2002-2004, we randomised 4345 normal birth weight neonates to NVAS (50,000 IU retinyl palmitate) or placebo together with their Bacillus Calmette-Guérin vaccination. In 2013, we visited the 1692 (39%) children now aged 8-10 years who were still living in the study area, and 1478 (87%) were found at home. Provided consent, a skin prick test was performed, and history of allergic symptoms was recorded. Associations of NVAS and atopy (defined as skin prick test reaction of ≥3mm) were analysed using binomial regression.

Of the 1430 children with a valid skin prick test, 228 (16%) were positive (more boys (20%) than girls (12%), p-value<0.0001). NVAS did not increase the overall risk of atopy (RR 1.10 [95% CI 0.87-1.40]). However, NVAS was associated with significantly increased risk among females (RR 1.78 [1.17-2.72]) but not among males (0.86 [0.64-1.15], p-value for interaction between NVAS and gender=0.005). Furthermore, NVAS was associated with increased risk of wheezing among females (RR 1.80 [1.03-3.17], but not among males, p-value for interaction=0.05).

The study corroborated previous observations; NVAS was associated with increased risk of atopy and wheezing, in this study only among females. Further studies on NVAS and atopy are warranted.

Publisher provides free PDF to patients and care givers

See also web

See any problem with this page? Report it (WORKS NOV 2021)